Abstract : Spondyloarthropathies are associated with a greater cardiovascular risk than expected based on the cardiac lesions known to occur in these diseases. The prevalence of several conventional risk factors is high in spondyloarthropathy patients, and chronic inflammation also contributes to premature plaque formation. In addition, susceptibility genes for spondyloarthropathies may be associated with an increased risk of cardiovascular disease. Finally, several drugs used to treat spondyloarthropathies may contribute to the occurrence of cardiovascular events. A careful evaluation of the cardiovascular risk profile is a key component of the management of patients with spondyloarthropathies.
https://hal.univ-brest.fr/hal-00750428
Contributeur : François Guerrero
<>
Soumis le : vendredi 9 novembre 2012 - 22:56:02
Dernière modification le : jeudi 29 novembre 2018 - 16:08:46
Ulric Vinsonneau, Aurore Brondex, Jacques Mansourati, Alain Saraux, Jean Christophe Cornily, et al.. Cardiovascular disease in patients with spondyloarthropathies.. Joint Bone Spine, Elsevier Masson, 2008, 75 (1), pp.18-21. 〈10.1016/j.jbspin.2007.04.011〉. 〈hal-00750428〉
